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Abstract
Background Keratoconus (KC) is associated with oxidative stress and hypoxia and as several times discussed, potentially with
inflammatory components. Inflammation, hypoxia, and oxidative stress may result in metabolic dysfunction and are directly
linked to each other. In the current study, we investigate the effect of hypoxia through NF-κB signaling pathways on iNOS,
hypoxia-induced factors (HIF), ROS, and proliferation of normal and KC human corneal fibroblasts (HCFs), in vitro.
Methods Primary human KC-HCFs and normal HCFs were isolated and cultured in DMEM/Ham’s F12 medium supplemented
with 5% fetal calf serum. Hypoxic conditions were generated and quantitative PCR andWestern blot analysis were performed to
examine NF-κB, iNOS, HIF, and PHD2 expression in KC and normal HCFs. ROS level was analyzed using flow cytometry and
proliferation by BrdU-ELISA.
Results Hypoxia increased NF-κB mRNA and protein expression in normal HCFs, but in KC-HCFs NF-κB mRNA and protein
expression remained unchanged. Hypoxic conditions upregulated iNOS mRNA expression of normal HCFs, but iNOS mRNA
expression of KC-HCFs and iNOS protein expression of both HCF types remained unchanged. Hypoxia downregulated HIF-1α
and HIF-2α mRNA expression in normal and KC-HCFs. PHD2 mRNA expression is upregulated under hypoxia in KC-HCFs,
but not in normal HCFs. PHD2 protein expression was upregulated by hypoxia in both HCF types. Total ROS concentration is
downregulated in normal and KC-HCFs under hypoxic conditions. Proliferation rate of KC-HCFs was upregulated through
hypoxia, but did not change in normal HCFs.
Conclusions Hypoxia increases NF-κB and iNOS mRNA expression in normal HCFs, but there does not seem to be enough
capacity in KC-HCFs to increase NF-κB and iNOS mRNA expression under hypoxia, maybe due to the preexisting oxidative
stress. HIF and PHD2 do not show altered iNOS regulation under hypoxic conditions in KC-HCFs, and therefore do not seem to
play a role in keratoconus pathogenesis. An increased proliferation of cells may refer to compensatory mechanisms under
hypoxia in KC. Understanding the mechanism of the altered regulation of NF-κB and iNOS in KC-HCFs will provide better
insight into the potential inflammatory component of the KC pathogenesis.
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Background
Keratoconus (KC) is a progressive corneal disease character-
ized by thinning and deformation, but with unknown etiology.
So far, KC has been characterized as a non-inflammatory cor-
neal disease, but several studies suggest an inflammatory
component in its development [1, 2]. Karamichos et al. sug-
gested the involvement of altered metabolic pathways in its
pathogenesis, but it has also been described that oxidative
stress plays a role [3–5].
It is known that reactive oxidative species (ROS) are ele-
vated in KC corneas [5]. The reason could be, among others,
altered metabolic pathways or hypoxic conditions due to
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mitochondrial dysfunction of mtDNA-mediated inflamma-
tion. If a hypoxic state is present due to altered metabolic
functions, these also have an influence on the oxidative state
and can act as a pro-inflammatory mediator. Both hypoxic
conditions and oxidative stress trigger an inflammatory cell
response [6].
In our previous study, we determined an increased induc-
ible nitric oxide synthase (iNOS) and nuclear factor kappa B
(NF-κB) mRNA expression in KC-HCFs compared with
normal cells [7]. This was accompanied by an increased
NF-κB protein expression, without a change in iNOS protein
levels.
iNOS converts L-arginine into nitric oxide (NO), which re-
acts as a free radical and is also part of the ROS/RNS state in the
cells. The induction of iNOS is mainly mediated by inflamma-
tory cytokines such as IL-1, TNF-α, and IFN-γ, but also by
lipopolysaccharides (LPS) in macrophages via NF-κB (Fig. 1).
However, several cell types constitutively express iNOS with-
out an inflammatory process [8]. It is also known that ROS
production by KC-HCFs is higher than that in HCFs.
The hypoxia-inducible factor α (HIFα) acts as an oxygen
sensor in the cellular response to reduced oxygen supply [9].
Its main subunits are HIF-1α and HIF-2α. Under hypoxic
conditions, HIFα is stabilized by prolyl-hydroxylases
(PHDs) and translocated into the cell nucleus. Then, the α
subunit forms a complex with HIFβ and acts as a transcription
factor in the hypoxic reaction, e.g., for iNOS (Fig. 2).
In keratoconus, cell density is reduced in all layers of the
cornea [10]. However, hypoxia can induce proliferation of
many cell types and is known as a regulatory factor [11]. All
factors, ROS/RNS and oxygen homeostasis via HIF-1α and
PHDs and proliferation, are involved in the interaction of in-
flammation and altered metabolic balance and influence each
other.
Fig. 1 Activation of iNOS
transcription through NF-κB
binding at the iNOS promotor re-
gion. The scheme displays the
activation of NF-κB by IFN-γ,
LPS, TNF-α, or IL-1β. NF-κB
can directly bind to the iNOS
promotor region to activate the
transcription of iNOS which is
able to start the production of ni-
tric oxide
Key messages
Keratoconus has been characterized as a non-inflammatory corneal disease, but several studies suggest an 
inflammatory component in its development.
Hypoxia increases NF-κB and iNOS mRNA expression in normal human corneal fibroblasts (HCFs), but there 
does not seem to be enough capacity in keratoconus human corneal fibroblasts (KC-HCFs) to increase NF-κB and 
iNOS mRNA expression under hypoxia, maybe due to the preexisting oxidative stress.
HIF and PHD2 do not show altered iNOS regulation under hypoxic conditions in KC-HCFs, and therefore do not 
seem to play a role in keratoconus pathogenesis.
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In this study, we investigated the regulation of NF-κB,
iNOS, HIF-1α, HIF-2α, and PHD expression; ROS, and pro-
liferation under hypoxic conditions in keratoconus corneal
fibroblasts compared with normal control cells, in vitro.
Methods
Cell culture
Eight normal human corneas were obtained from the LIONS
Cornea Bank Saar-Lor-Lux, Trier/Westpfalz, and 8 corneas
fromKC patients were obtained from elective penetrating ker-
atoplasties. For the keratoconus corneas, all eyes with previ-
ous ocular surgery have been excluded. Donor corneas, which
did not match the criteria for transplantation (less than 2000
endothelial cells/mm2), have been used for the experiments.
To isolate keratocytes, human corneoscleral/corneal but-
tons were first rinsed in PBS (Merck Sigma-Aldrich Chemie
GmbH, Taufkirchen, Deutschland). The central corneal button
was cut into small pieces and was incubated in culture medi-
um with 1.0 mg/ml collagenase A (Roche Diagnostic GmbH,
Mannheim, Germany, No. 10103578001) for 24 h at 37 °C.
The digested tissue and cells were centrifuged at 800 g for
7 min and resuspended in culture medium, which consisted
of basic medium (DMEM/F12, Sigma-Aldrich® GmbH,
Geisenheim, Germany, No. 11594426) supplemented by 5%
fetal calf serum (FCS) (Fisher Scientific GmbH, Schwerte,
Germany, No. 11573397). The cell suspension was seeded
in 75-cm2 culture flasks, using DMEM/F12 (+ 5% FCS).
Thereafter, medium was changed every 2 to 3 days until cells
reached confluence. As keratocytes were cultured with FCS,
we specify them further on in the manuscript as “human cor-
neal fibroblasts” (HCF) or “keratoconus human corneal fibro-
blast” (KC-HCF) [12].
The cell passages 3 to 8 were used for the experiments.
Hypoxic conditions were generated using 150 μM CoCl2
(PHD inhibitor, Sigma-Aldrich® GmbH, Geisenheim,
Germany, No. 60818) for 4 h, 24 h, and 48 h, to evaluate
the time-point with changes in NF-κB, iNOS, HIF-1α, and
HIF-2α mRNA and protein expression. Since CoCl2 is an
inhibitor of prolyl-hydroxylases, which induce a chemical
hypoxia, we used 1% O2 atmosphere in a hypoxic chamber
(Modular Incubator Chamber, Billups-Rothenberg, Inc., CA,
USA) to examine the effect of hypoxia on prolyl-hydroxylase
2 [13]. For PHD2 analysis, we generated 1% O2 for 48 h for
PHD2 mRNA and protein expression measurements. Shortly,
the cell culture flask was placed in a hypoxic chamber; the
chamber was connected to a gas mixture (1% O2, 5% Co2,
94% N2) and was filled with the gas for 2 min. This procedure
was repeated after 24 h. The chamber including the cell cul-
ture flasks was incubated at 37 °C in the cell culture incubator.
RNA isolation and cDNA synthesis
Human normal and KC-HCFs were seeded in 75-cm2 cell
culture flasks. After reaching confluence, the cells were har-
vested using Trypsin-EDTA (0.05% trypsin/0.02% EDTA,
Fig. 2 Under normoxia, HIF-α is hydroxylated by PHDs, which target
HIF-α for von Hippel - Lindau protein degradation. Under hypoxic con-
ditions, through inflammation or oxidative stress, HIF-α transcription is
induced via NF-κ dependent mechanism. HIF-α is located in the cell
nucleus and binds to the β unit and serves as a transcription factor, e.g.
for iNOS.
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Sigma-Aldrich® GmbH, Geisenheim, Germany). The RNA
isolation was performed according to the manufacturer’s pro-
tocol (ISOLATE II RNA/DNA/Protein Kit, Luckenwalde,
Germany) and RNA was stored at − 80 °C until cDNA syn-
thesis (One Taq® RT-PCR Kit, New England Biolabs INC,
Frankfurt, Germany). For cDNA, 1 μg of total RNAwas used
as template for all samples. The cDNA was stored at − 20 °C
until further use.
Quantitative PCR
For quantitative PCR (qPCR), Tata-binding protein (TBP),
NF-κB (RELA/NF-κB p65), HIF-1α, HIF-2α, and PHD2
validated primer sets for use in SYBR Green–based quantita-
tive PCR, obtained from Qiagen GmbH (Hilden, Germany),
were utilized. For iNOS, primers were synthesized by MWG
Eurofins (Table 1).
The qPCR experiment was carried out for all KC samples
and for controls in 96-well plates using AceQ SYBR qPCR
Master Mix (Vazyme Biotech, China) and a PCR
Thermocycler QuantStudio 5 Real-Time PCR System
(ThermoFisher Scientific™ GmbH, Dreieich, Germany).
The relative normalized expression of NF-κB, iNOS, HIF-
1α, HIF-2α, and PHD2 was compared with the respective
TBP reference gene. TheΔΔ cycle threshold (Ct) fold change
was quantified by comparing the Ct obtained from the un-
known samples compared with the Ct of the reference gene
TBP. For qPCR, the amplification conditions were 95 °C for
10 s, 64 °C for 10 s, and 72 °C for 45 s and 40 cycles.
Western blot analysis
To determine NF-κB, iNOS, HIF-1α, HIF-2α, and PHD2
protein expression in corneal fibroblasts, 20 μg protein of
normal or KC human corneal fibroblasts, obtained with
ISOLATE II RNA/DNA/Protein Kit (Luckenwalde,
Germany), was used (Western blot analysis). Antibodies
against NF-κB p65, HIF-1α, HIF-2α, and PHD2 were pur-
chased from Cell Signaling Technology (Frankfurt am Main,
Germany), and anti-iNOS antibody from Abcam (Cambridge,
UK). After boiling the samples for 5 min at 95 °C, proteins
were separated using NuPAGE™ bis-tris precast 4–12% bis-
tris gels (ThermoFisher Scientific™ GmbH, Dreieich,
Germany). Following protein separation, the proteins were
transferred onto a nitrocellulose membrane with the Trans
Blot Turbo Transfer System (BioRad, Hercules, CA, USA).
Primary antibodies were diluted in WesternFroxx anti-rabbit
HRP solution containing blocking reagent and secondary an-
tibody (BioFroxx GmbH, Einhausen, Germany). For loading
control, blots were stripped in stripping buffer (BioFroxx),
and reprobed with calnexin antibody (Enzo Life Sciences
Ag, Lausen, Switzerland, No. ADI-SPA-865). Visualization
was performed using an imaging system (LAS 4000 system,
Fujifilm).
Protein measurement
For Western blot analysis, protein quantity was determined
according to Bradford’s method, using bovine serum albumin
as a standard. The absorbance was measured at 595 nm and
the concentrations were quantified.
ROS detection
To evaluate total ROS concentration in keratocytes, the Total
ROS assay kit for flow cytometry was used (Thermo Fisher
Scientific, Karlsruhe, Germany). Shortly, cells were seeded
into 6-well plates and were cultivated until 90% confluence.
One hundred fifty micrometers micromolar (150 µM) of the
hypoxia-mimicking agent CoCl2 was used to generate hypox-
ic conditions for 48 h. Thereafter, cells were harvested and
stained with ROS assay stain for 60 min at 37 °C. FACS
analysis was performed using FACS Canto (Becton
Dickinson, Heidelberg, Germany) of the 488 nm FITC chan-
nel. Ten thousand events were acquired for each analysis.
Geometric mean of fluorescence intensity was evaluated using
WinMDI 2.9.
Table 1 Primer pairs for qPCR
Targeted cDNA Gene symbol 5′ forward primer 3′ or Qiagen Cat. No. Amplicon size bp







HIF-1α HIF1A QT00083664 104
HIF-2α EPAS1 QT00069587 127
HIF-PHD2 EGLN1 QT00222684 123
P4H-TM P4HTM QT00041048 87
TBP TBP QT00000721 132
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BrdU assay
Proliferation of HCFs was assessed after culturing the cells
under hypoxic conditions using 150 μM CoCl2 with the pro-
liferation ELISA-BrdU kit, by the measurement of BrdU (5-
bromo-2′deoxyuridine) incorporation in the newly synthe-
sized cellular DNA. HCFs were seeded in a 96-multiwell plate
at a density of 6 × 103 cells/cm2 in 100 μl culture medium per
well. After a growth period of 24 h, the culture medium was
changed to a CoCl2 containing culture medium, at 37 °C for
48 h. The test was performed according to the manufacturer’s
protocol (Cell Proliferation ELISA, BrdU colorimetric,
Roche, No 11647229001, Sigma-Aldrich® GmbH,
Geisenheim, Germany).
Statistical analysis
For statistical analysis, the GraphPad Prism 7.04 was used.
Statistical analysis was performed using the Mann-Whitney
U test for comparison between groups. p values below 0.05
were considered statistically significant.
Results
NF-κB, iNOS, HIF-1α, HIF-2α, and PHD2 mRNA
expression and Western blot analysis under normoxic
and hypoxic conditions
mRNA and Western blot measurements were performed fol-
lowing hypoxic conditions for 4, 24, and 48 h. Below we
summarize results for the time-points with changes in
mRNA and protein expression, which is also summarized at
Table 2. For the other time-points, without changes in mRNA
and protein expression, compared with controls (under hyp-
oxic conditions) data are not shown below or at Table 2.
Figure 3 displays NF-κB, iNOS, HIF-1α, HIF-2α, and
PHD2 mRNA and protein expression under normoxic and
hypoxic conditions. NF-κB mRNA is displayed after 4 h and
iNOS, HIF-1α, HIF-2α, and PHD2 mRNA after 48 h of hyp-
oxic conditions. Hypoxic conditions for Western blot analysis
of NF-κB iNOS, HIF-1α, HIF-2α, and PHD2 were 48 h.
In KC-HCFs,NF-κBmRNA (p = 0.0098) and protein (p =
0.0012) expression was increased compared with normal
HCFs, under normoxic conditions. Through hypoxia for 4 h,
NF-κB mRNA expression increased in normal HCFs (p =
0.0089), but NF-κB mRNA expression in KC-HCFs and
NF-κB protein expression in normal and KC-HCFs remained
unchanged (p > 0.721).
iNOS mRNA expression was significantly higher in KC-
HCFs than in normal HCFs (p < 0.0001) under normoxic condi-
tions, but iNOS protein expression did not differ between both
HCF types (p = 0.841). Hypoxic conditions for 48 h significantly
increased iNOSmRNA expression of normal HCFs (p = 0.044),
but iNOS mRNA expression of KC-HCFs and iNOS protein
expression of both HCF types did not change significantly
through hypoxia (p > 0.421), compared with controls.
HIF-1α and HIF-2α mRNA and protein expression did
not differ between both HCF types, under normoxic condi-
tions (p > 0.469). Following hypoxic conditions for 48 h,
HIF-1α and HIF-2α mRNA expression was decreased in
normal (p = 0.014 for both) and KC-HCFs (p < 0.0001 for
both), compared with controls, but HIF-1α and HIF-2α pro-
tein expression remained unchanged (p > 0.393).
Table 2 Comparison of NF-κB, iNOS, HIF-1α, HIF-2α, PHD2
mRNA, and protein expression and total ROS concentration under
normoxic and hypoxic conditions in normal HCFs and in KC-HCFs
(Mann-Whitney U test). NF-κB mRNA is displayed after 4 h; iNOS,
HIF-1α, and HIF-2α after 48 h; and PHD2 mRNA after 4 h and 48 h
of hypoxic conditions. Hypoxic conditions for Western blot analysis of
NF-κB iNOS, HIF-1α, HIF-2α, and PHD2 were 48 h (*p < 0.05;
**p < 0.01; ***p < 0.001)
Parameters Normoxic conditions Normoxic vs hypoxic conditions (48 h)
Controls (HCFs) vs KC-HCFs Normal HCFs KC-HCFs
NF-κB mRNA expression Increased in KC-HCFs**7 Increased** Unchanged
NF-κB protein expression Increased in KC-HCFs**7 Unchanged Unchanged
iNOS mRNA expression Increased in KC-HCFs***7 Increased* Unchanged
iNOS protein expression Unchanged Unchanged Unchanged
HIF-1α and HIF-2α mRNA expression Unchanged Decreased* Decreased***
HIF-1α and HIF-2α protein expression Unchanged Unchanged Unchanged






PHD2 protein expression Unchanged Increased* Increased*
Total ROS concentration Increased in KC-CFs** Decreased** Decreased*
Proliferation rate of HCFs Decreased in KC-HCFs* Unchanged Increased**
No. 7 indicates the literature reference given in the bibliography
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Fig. 3 Effect of hypoxia on NF-κB, iNOS, HIF-1α, HIF-2α, and PHD2
mRNA and protein expression (normoxic conditions: white bars; hypoxic
conditions: blue bars). Hypoxic conditions for human corneal fibroblasts
(HCFs) and keratoconus human corneal fibroblasts (KC-HCFs) were
performed using 150 μM CoCl2 for NF-κB (4 h), and iNOS, HIF-1α,
and HIF-2α (48 h) for PHD2 1% O2 atmosphere were generated in a
hypoxic chamber for 48 h. Significant differences are indicated. a–e
Quantitative mRNA analysis of NF-κB, iNOS, HIF-1α, HIF-2α, and
PHD2. Data show mean ± SEM of at least 8 independent experiments
in duplicate. f–j Relative quantification of Western blot analysis.
Calnexin was used as loading control and to calculate the relative protein
expression levels. k–o Representative Western blots of NF-κB, iNOS,
HIF-1α, HIF-2α, and PHD2 (*p < 0.05; **p < 0.01; ***p < 0.001)
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Under normoxic conditions, PHD2 mRNA and protein
expression did not differ between normal and KC-HCFs
(p > 0.558). Under hypoxic conditions for 4 h, PHD2
mRNA expression increased in HCFs (p = 0.0069) and de-
creased in KC-HCFs (p = 0.0046) (data not shown at figures).
Under hypoxic conditions for 48 h, PHD2mRNA expression
remained unchanged in normals (p = 0.496), but increased in
KC-HCFs (p = 0.0096). PHD2 protein expression increased
in both HCF types following 48 h of hypoxia (p = 0.031 for
both).
Total ROS concentration in KC and normal HCFs
Under normoxic conditions, total ROS concentration was sig-
nificantly higher in KC-HCFs than in normal HCFs (p =
0.0027). Hypoxic conditions for 48 h resulted in decreased
total ROS concentration in normal (p = 0.0079) and KC-
HCFs (p = 0.025), compared with controls (Fig. 4).
Proliferation of KC and normal HCFs
Under normoxic conditions, proliferation rate in KC-HCFs
was lower as in normal HCFs (p = 0.023). Through hypoxia
for 48 h, proliferation rate of KC-HCFs increased significantly
(p = 0.0052), but did not change in normal HCFs (p = 0.244)
(Fig. 5).
Discussion
The pathogenesis of keratoconus is still unknown, but sev-


































p=0.0027Fig. 4 Total reactive oxygen
species (ROS) concentration un-
der normoxic (white bars) and
hypoxic conditions (blue bars)
using 150 μM CoCl2 for 48 h in
normal and KC-HCFs. KC-HCFs
show a higher ROS level than
control cells. The concentration of
ROS is reduced in both cell types
following hypoxia. Data were





































Fig. 5 Proliferation under
normoxic (white bars) and
hypoxic conditions (blue bars)
using 150 μM CoCl2 for 48 h in
normal and KC-HCFs. The
proliferation rate is reduced in
KC-HCFs compared with normal
cells. Hypoxia increased prolifer-
ation in KC-KCFs, but not in
normal controls. Data were pre-
sented as mean ± SEM of 8 inde-
pendent experiments. Significant
differences are indicated
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been described. These include genetic, metabolic, and hor-
monal changes that are correlated with the disease [2,
14–18]. Some of these changes can be associated with in-
creased ROS production in corneal fibroblasts of KC patients
[3, 5].
KC is traditionally classified as a non-inflammatory corne-
al disease. However, in recent years, numerous study groups
have demonstrated elevated pro-inflammatory cytokine con-
centrations in tear fluid of KC patients [19–23]. An inflamma-
tory response is often associated with hypoxia and altered
oxidative stress levels [6]. In our previous study, we described
that the expression of iNOS mRNA in KC keratocytes is in-
creased compared with normal cells [7], but without a detect-
able change in the iNOS protein. Normally, iNOS is expressed
under inflammatory conditions via the NF-κB activation
mechanism to produce more NO for the immune response
[24]. However, there are also some cell types that permanently
express iNOS. The function of constitutively expressed iNOS
is not yet fully understood.
In this study, we investigated NF-κB, iNOS, HIF-1α, and
HIF-2α as well as PHD2 expression, ROS production, and
proliferation rate under hypoxic conditions in keratoconus
corneal fibroblasts in vitro. Our study describes the altered
regulation of KC-HCFs, compared with normal HCFs under
hypoxic conditions. As the study was performed in cell culture
cells, the growth and incubation conditions for the cells were
optimal. Therefore, limitation of our study is that a compari-
son with “in vivo” is difficult.
Our results showed that the regulation of these parameters
under hypoxic conditions is altered in KC-HCFs compared
with normal corneal fibroblasts. NF-κB and iNOS mRNA
expression is increased in KC-HCFs compared with HCFs.
After induction of a hypoxic environment, NF-κB and iNOS
mRNA expression is increased in HCFs but not in KC-HCFs.
One could speculate that KC-HCFs do not have more capacity
to increase NF-κB and iNOS expression.
It might also be possible that KC-HCFs counteract a higher
expression of NF-κB and iNOS to avoid an even higher
mRNA concentration of iNOS.
The hypoxia-inducible factor (HIF) is a key regulator of
oxygen consumption and responsible for the induction of sev-
eral genes. Under hypoxic conditions, HIF is stabilized by
prolyl-hydroxylases (PHDs). The HIF-α translocates into the
nucleus and binds to the HIF-β unit and serves as a transcrip-
tion factor for several genes, e.g., for iNOS.
It is quite common to use different times of hypoxic expo-
sure to simulate acute, prolonged, or even chronic hypoxia
[25].
Acute hypoxia (4 h) may have a different effect on the
activation of HIF, NF-kB, and iNOS than continuous (24 h)
or chronic (48 h) hypoxic induction. Therefore, we chose dif-
ferent hypoxic exposure times, in order to detect a possible
difference between responses of normal and KC cells. The
HIF-1α and HIF-2α subunits are similar in function, but are
expressed differently in different tissues. Although the exper-
iments did not show differences in HIF-1α and HIF-2α
mRNA and protein expression in KC and normal HCFs, as
half-life time of HIF proteins is still extremely short (4–6 min)
under hypoxia, we could also have missed the presence of the
HIF proteins during our measurement series [26]. Likewise,
the expression of HIF-1α and HIF-2α seems to be regulated in
the same way in normal and KC-HCFs.
The explanation could be that the iNOS regulation is not
triggered by HIF, but is regulated directly by NF-κB. The
homodimer NF-κp65 (which was measured in our present
study as mRNA and protein) can bind directly to the iNOS
gene promoter to regulate iNOS expression in myeloid cells
[27], and a similar regulatory mechanism might exist in
keratoconus cells (Fig. 1). This theory is supported by the
fact that PHD2 mRNA and protein expression is similar in
HCFs and KC-HCFs after 48 h, although 44 h earlier, PHD2
mRNA is still in increased in normal HCFs and decreased in
KC-HCFs (after 4 h). This behavior may be explained by
the metabolic dysfunction due to oxidative stress in KC
cells.
It is known that the ROS level of keratoconus cells is
higher than in healthy cells. Our studies are consistent with
the experiments of Chwa et al., who also reported higher
ROS activity of KC-HCFs compared with normal controls
[5]. However, there are no studies on the effect of hypoxia
on ROS production in corneal fibroblasts. In our experi-
ments, we could show that ROS concentration was lower
in HCFs and KC-HCFs after induction of a hypoxic
environment.
Hypoxia in glioma cells has been shown to increase the
production of free radicals, notably ROS [28]. While cellular
responses to hypoxia have been studied extensively, it remains
controversial, whether ROS levels increase or decrease at low
O2, depending on cell type [29].
In our case, corneal fibroblasts behaved similar to dermal
fibroblasts, with a decrease of ROS concentration following
hypoxia [29].
Oxidative stress may also regulate the proliferation rate of
some cells. The proliferation rate of KC-HCFs was reduced
compared with normal cells. Since several proteins like
adaptor-related protein complex 2 (AP2B1) and immunoglob-
ulin Lambda-like polypeptide 1(IGLL1), cell division cycle,
and apoptosis regulator 1 (CCAR1) are altered in KC, there
may be an altered proliferation and apoptosis-related program
of these cells [30]. Our experiments show that the proliferation
rate after hypoxia increases only in KC-HCFs, but not in nor-
mal control cells. It could be a counter-regulation to increase
the proliferation of cells, since in keratoconus there is a re-
duced cell density in the stroma. Nevertheless, future studies
have to clarify the exact proliferation-related alterations in
KC-HCFs.
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Many of the known cell physiological changes in
keratoconus can be associated with inflammation, oxidative
stress, and hypoxia. Our experiments suggest that the response
of normal and KC human fibroblasts to a hypoxic environ-
ment may differ to some extent.
Conclusion
In summary, a hypoxic environment increases NF-κB and
iNOS mRNA expression in normal HCFs but not in KC-
HCFs. It is possible that the already existing oxidative
stress in KC cells leads to an altered regulation of these
parameters, or that the cells no longer have the capacity to
further increase NF-κB and iNOS mRNA due to the meta-
bolic changes.
NF-κB regulation is different in normal and KC cells; it can
be speculated that KC cells need longer time to normalize the
NF-kB protein following hypoxia, due to the elevated stress
level of these cells.
HIF and PHD2 show no altered iNOS regulation under
hypoxic conditions in KC-HCFs and normal HCF, so they
do not seem to play a role in keratoconus pathogenesis.
Increased cell proliferation may indicate compensatory
mechanisms under hypoxia in KC.
Further studies should investigate the trigger mechanism of
NF-κB and the binding of the homodimer NF-κB p65 to the
iNOS promoter of corneal fibroblasts.
The relationship of an inflammatory component to oxida-
tive stress should be further investigated, to better understand
the pathogenesis of the disease.
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